• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亚氨基糖N-丁基脱氧野尻霉素可抑制人乙型肝炎病毒的分泌。

Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin.

作者信息

Block T M, Lu X, Platt F M, Foster G R, Gerlich W H, Blumberg B S, Dwek R A

机构信息

Jefferson Cancer Institute, Jefferson Medical College, Philadelphia, PA 19107.

出版信息

Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2235-9. doi: 10.1073/pnas.91.6.2235.

DOI:10.1073/pnas.91.6.2235
PMID:8134380
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC43345/
Abstract

The imino sugar N-butyldeoxynojirimycin (NBDNJ) is a potent inhibitor of the oligosaccharide-trimming enzyme alpha-glucosidase I. Hepatitis B virus (HBV) contains three surface proteins (HBs proteins) of different sizes that are singly or doubly N-glycosylated and are essential for the formation of infectious virus. Therefore, the replication and secretion of HBV in the human hepatoma cell line HepG2 were studied in the presence of NBDNJ. In the stably HBV-transfected HepG 2.2.15 cells and in HBV-infected HepG2 cells, NBDNJ suppressed secretion of HBV particles and caused intracellular retention of HBV DNA. The secretion of subviral particles was less affected. These data suggest that inhibitors of oligosaccharide trimming may be useful for antiviral therapy of hepatitis B and for the study of the intracellular transport of the viral glycoproteins.

摘要

亚氨基糖N-丁基脱氧野尻霉素(NBDNJ)是寡糖修剪酶α-葡萄糖苷酶I的有效抑制剂。乙型肝炎病毒(HBV)含有三种不同大小的表面蛋白(HBs蛋白),这些蛋白单糖基化或双糖基化,对于感染性病毒的形成至关重要。因此,在NBDNJ存在的情况下,研究了HBV在人肝癌细胞系HepG2中的复制和分泌。在稳定转染HBV的HepG 2.2.15细胞和HBV感染的HepG2细胞中,NBDNJ抑制了HBV颗粒的分泌,并导致HBV DNA在细胞内滞留。亚病毒颗粒的分泌受影响较小。这些数据表明,寡糖修剪抑制剂可能对乙型肝炎的抗病毒治疗以及病毒糖蛋白的细胞内运输研究有用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3fa/43345/f35dd6355741/pnas01128-0266-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3fa/43345/5aabda4a3e7d/pnas01128-0264-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3fa/43345/849a9741d87e/pnas01128-0264-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3fa/43345/0e01303ac58c/pnas01128-0265-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3fa/43345/cc679ba41ad6/pnas01128-0266-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3fa/43345/f35dd6355741/pnas01128-0266-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3fa/43345/5aabda4a3e7d/pnas01128-0264-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3fa/43345/849a9741d87e/pnas01128-0264-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3fa/43345/0e01303ac58c/pnas01128-0265-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3fa/43345/cc679ba41ad6/pnas01128-0266-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3fa/43345/f35dd6355741/pnas01128-0266-b.jpg

相似文献

1
Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin.亚氨基糖N-丁基脱氧野尻霉素可抑制人乙型肝炎病毒的分泌。
Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2235-9. doi: 10.1073/pnas.91.6.2235.
2
alpha-Glucosidase inhibitors have a prolonged antiviral effect against hepatitis B virus through the sustained inhibition of the large and middle envelope glycoproteins.α-葡萄糖苷酶抑制剂通过持续抑制大、中包膜糖蛋白对乙型肝炎病毒具有持久的抗病毒作用。
Antivir Chem Chemother. 2006;17(5):259-67. doi: 10.1177/095632020601700503.
3
Treatment of hepatitis B virus-infected cells with alpha-glucosidase inhibitors results in production of virions with altered molecular composition and infectivity.用α-葡萄糖苷酶抑制剂处理乙肝病毒感染的细胞会导致产生分子组成和感染性改变的病毒粒子。
Antiviral Res. 2007 Oct;76(1):30-7. doi: 10.1016/j.antiviral.2007.04.004. Epub 2007 May 22.
4
Evidence that N-linked glycosylation is necessary for hepatitis B virus secretion.N-连接糖基化对于乙型肝炎病毒分泌是必需的证据。
Virology. 1995 Nov 10;213(2):660-5. doi: 10.1006/viro.1995.0038.
5
Protocatechuic acid inhibits hepatitis B virus replication by activating ERK1/2 pathway and down-regulating HNF4α and HNF1α in vitro.原儿茶酸在体外通过激活ERK1/2通路并下调肝细胞核因子4α(HNF4α)和肝细胞核因子1α(HNF1α)来抑制乙型肝炎病毒复制。
Life Sci. 2017 Jul 1;180:68-74. doi: 10.1016/j.lfs.2017.05.015. Epub 2017 May 12.
6
In vitro infection of human hepatoma cells (HepG2) with hepatitis B virus (HBV): spontaneous selection of a stable HBV surface antigen-producing HepG2 cell line containing integrated HBV DNA sequences.乙型肝炎病毒(HBV)对人肝癌细胞(HepG2)进行体外感染:自发筛选出一种稳定产生 HBV 表面抗原的 HepG2 细胞系,该细胞系含有整合的 HBV DNA 序列。
J Gen Virol. 1994 Oct;75 ( Pt 10):2681-9. doi: 10.1099/0022-1317-75-10-2681.
7
Evidence for dual effects of DNA-reactive bile acid derivatives (Bamets) on hepatitis B virus life cycle in an in vitro replicative system.DNA反应性胆汁酸衍生物(Bamets)在体外复制系统中对乙型肝炎病毒生命周期具有双重作用的证据。
Antivir Chem Chemother. 2002 Nov;13(6):371-80. doi: 10.1177/095632020201300605.
8
KNK437 Inhibits Replication and Transcription of the Hepatitis B Virus.KNK437抑制乙型肝炎病毒的复制和转录。
Bing Du Xue Bao. 2017 Jan;33(1):24-35.
9
The HBV-producing cell line HepG2-4A5: a new in vitro system for studying the regulation of HBV replication and for screening anti-hepatitis B virus drugs.产生乙肝病毒的细胞系HepG2-4A5:一种用于研究乙肝病毒复制调控及筛选抗乙肝病毒药物的新型体外系统。
Virology. 1996 Feb 1;216(1):214-8. doi: 10.1006/viro.1996.0049.
10
A substituted tetrahydro-tetrazolo-pyrimidine is a specific and novel inhibitor of hepatitis B virus surface antigen secretion.一种取代的四氢-四唑并嘧啶是乙型肝炎病毒表面抗原分泌的特异性新型抑制剂。
Antimicrob Agents Chemother. 2007 Dec;51(12):4427-37. doi: 10.1128/AAC.00541-07. Epub 2007 Sep 17.

引用本文的文献

1
Antiviral Activity of 1-Deoxynojirimycin Extracts of Mulberry Leaves Against Porcine Epidemic Diarrhea Virus.桑叶1-脱氧野尻霉素提取物对猪流行性腹泻病毒的抗病毒活性
Animals (Basel). 2025 Apr 23;15(9):1207. doi: 10.3390/ani15091207.
2
Exploring the Potential of Iminosugars as Antivirals for Crimean-Congo Haemorrhagic Fever Virus, Using the Surrogate Hazara Virus: Liquid-Chromatography-Based Mapping of Viral N-Glycosylation and In Vitro Antiviral Assays.利用替代病毒哈扎拉病毒探索亚氨基糖作为克里米亚-刚果出血热病毒抗病毒药物的潜力:基于液相色谱的病毒N-糖基化图谱分析及体外抗病毒试验
Pathogens. 2023 Mar 1;12(3):399. doi: 10.3390/pathogens12030399.
3

本文引用的文献

1
Effects of the imino sugar N-butyldeoxynojirimycin on the N-glycosylation of recombinant gp120.亚氨基糖N-丁基脱氧野尻霉素对重组糖蛋白120 N-糖基化的影响
J Biol Chem. 1993 Jan 5;268(1):570-6.
2
Glucose removal from N-linked oligosaccharides is required for efficient maturation of certain secretory glycoproteins from the rough endoplasmic reticulum to the Golgi complex.从N-连接寡糖中去除葡萄糖是某些分泌性糖蛋白从糙面内质网到高尔基体复合体高效成熟所必需的。
J Cell Biol. 1984 May;98(5):1720-9. doi: 10.1083/jcb.98.5.1720.
3
Particles associated with Australia antigen in the sera of patients with leukaemia, Down's Syndrome and hepatitis.
Glucosidase Inhibitors Screening in Microalgae and Cyanobacteria Isolated from the Amazon and Proteomic Analysis of Inhibitor Producing sp. GFB01.
从亚马逊地区分离的微藻和蓝细菌中筛选葡糖苷酶抑制剂以及产抑制剂菌株GFB01的蛋白质组学分析
Microorganisms. 2021 Jul 27;9(8):1593. doi: 10.3390/microorganisms9081593.
4
Binding of Nanoparticles Harboring Recombinant Large Surface Protein of Hepatitis B Virus to Scavenger Receptor Class B Type 1.纳米颗粒携带乙型肝炎病毒重组大表面蛋白与清道夫受体 B 类 1 的结合。
Viruses. 2021 Jul 10;13(7):1334. doi: 10.3390/v13071334.
5
Structure of human endo-α-1,2-mannosidase (MANEA), an antiviral host-glycosylation target.人内-α-1,2-甘露糖苷酶(MANEA)的结构,一种抗病毒宿主糖基化靶标。
Proc Natl Acad Sci U S A. 2020 Nov 24;117(47):29595-29601. doi: 10.1073/pnas.2013620117. Epub 2020 Nov 5.
6
N-Glycosylation and N-Glycan Processing in HBV Biology and Pathogenesis.HBV 生物学和发病机制中的 N-糖基化和 N-聚糖加工。
Cells. 2020 Jun 4;9(6):1404. doi: 10.3390/cells9061404.
7
SERINC5 Inhibits the Secretion of Complete and Genome-Free Hepatitis B Virions Through Interfering With the Glycosylation of the HBV Envelope.SERINC5通过干扰乙肝病毒包膜的糖基化来抑制完整和无基因组乙肝病毒颗粒的分泌。
Front Microbiol. 2020 Apr 30;11:697. doi: 10.3389/fmicb.2020.00697. eCollection 2020.
8
Molecular and functional insights into a novel teleost malectin from big-belly seahorse Hippocampus abdominalis.分子和功能研究揭示了来自大腹海马 Hippocampus abdominalis 的新型硬脂酰基转移酶。
Fish Shellfish Immunol. 2020 Apr;99:483-494. doi: 10.1016/j.fsi.2020.02.044. Epub 2020 Feb 20.
9
Mechanisms of Antiviral Activity of Iminosugars Against Dengue Virus.脒糖类抗病毒活性的机制对登革热病毒。
Adv Exp Med Biol. 2018;1062:277-301. doi: 10.1007/978-981-10-8727-1_20.
10
A direct role for hepatitis B virus X protein in inducing mitochondrial membrane permeabilization.乙型肝炎病毒X蛋白在诱导线粒体膜通透性改变中起直接作用。
J Viral Hepat. 2018 Apr;25(4):412-420. doi: 10.1111/jvh.12831. Epub 2018 Jan 24.
白血病、唐氏综合征和肝炎患者血清中与澳大利亚抗原相关的颗粒。
Nature. 1968 Jun 15;218(5146):1057-9. doi: 10.1038/2181057a0.
4
Intracellular assembly and packaging of hepatitis B surface antigen particles occur in the endoplasmic reticulum.乙型肝炎表面抗原颗粒的细胞内组装和包装发生在内质网中。
J Virol. 1986 Jun;58(3):884-92. doi: 10.1128/JVI.58.3.884-892.1986.
5
Effects of an extract from Phyllanthus niruri on hepatitis B and woodchuck hepatitis viruses: in vitro and in vivo studies.叶下珠提取物对乙型肝炎病毒和土拨鼠肝炎病毒的作用:体外和体内研究
Proc Natl Acad Sci U S A. 1987 Jan;84(1):274-8. doi: 10.1073/pnas.84.1.274.
6
Evaluation of the role of rat liver Golgi endo-alpha-D-mannosidase in processing N-linked oligosaccharides.大鼠肝脏高尔基体内切α-D-甘露糖苷酶在加工N-连接寡糖中的作用评估。
J Biol Chem. 1988 Mar 15;263(8):3990-8.
7
Inhibitors of protein glycosylation and glycoprotein processing in viral systems.病毒系统中蛋白质糖基化和糖蛋白加工的抑制剂。
Pharmacol Ther. 1987;33(2-3):221-86. doi: 10.1016/0163-7258(87)90066-0.
8
Aminosugar derivatives as potential anti-human immunodeficiency virus agents.氨基糖衍生物作为潜在的抗人类免疫缺陷病毒药物。
Proc Natl Acad Sci U S A. 1988 Dec;85(23):9229-33. doi: 10.1073/pnas.85.23.9229.
9
Inhibition of HIV replication by amino-sugar derivatives.氨基糖衍生物对HIV复制的抑制作用。
FEBS Lett. 1988 Sep 12;237(1-2):128-32. doi: 10.1016/0014-5793(88)80185-6.
10
Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA.用克隆的乙型肝炎病毒DNA转染Hep G2细胞后乙型肝炎病毒颗粒的产生。
Proc Natl Acad Sci U S A. 1987 Feb;84(4):1005-9. doi: 10.1073/pnas.84.4.1005.